Michał M. Farkowski

ORCID: 0000-0003-1673-7712
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac Structural Anomalies and Repair
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Imaging and Diagnostics
  • Neurological disorders and treatments
  • Cardiac tumors and thrombi
  • Pharmaceutical Economics and Policy
  • Cardiovascular Effects of Exercise
  • Acute Myocardial Infarction Research
  • Trauma and Emergency Care Studies
  • Cardiomyopathy and Myosin Studies
  • Venous Thromboembolism Diagnosis and Management
  • Acute Ischemic Stroke Management
  • Management and Organizational Practices
  • ECG Monitoring and Analysis
  • Cardiac Arrest and Resuscitation
  • Bacterial Infections and Vaccines
  • Cancer, Lipids, and Metabolism
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Heart rate and cardiovascular health

Ministry of Interior and Administration
2023-2025

Institute of Cardiology
2016-2025

Central Clinical Hospital
2023

Foundation of Cardiac Surgery Development
2022-2023

Cardinal Stefan Wyszyński University in Warsaw
2017-2022

Centralny Szpital Kliniczny
2022

Gdańsk Medical University
2020

Corona (Poland)
2012-2019

Institute of Psychiatry and Neurology
2019

Medical University of Warsaw
2019

Abstract Aims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated risk AF-related complications. The aim this document to summarize key outcomes 9th AFNET/EHRA Consensus Conference Atrial Fibrillation NETwork (AFNET) European Heart Rhythm Association (EHRA). Methods results Eighty-three international experts met Münster for 2 days September 2023. Key findings...

10.1093/europace/euae070 article EN cc-by-nc EP Europace 2024-03-22

The Council of Cardio-Oncology the European Society Cardiology developed an on-line anonymous survey to provide overall picture current practice on use mobile and wearable digital devices in cardio-oncology potential barriers their large-scale applicability. Between June 2023 January 2024, online questionnaire was completed by 220 healthcare professionals from 55 countries. greatest number respondents reported that mobile/wearable have a role all active cancer patients for measuring heart...

10.1093/ehjdh/ztae082 article EN cc-by-nc-nd European Heart Journal - Digital Health 2025-01-21

Aim: The aim of this ambispective, two-center, observational study was to evaluate the clinical characteristics and 3-years prognosis patients with non-Stelevation myocardial infarction (NSTEMI) AF. Materials methods: Patients hospitalized a diagnosis NSTEMI were included. Baseline demographic features, in-hospital procedures, occurrence cardiovascular events in sinus rhythm (SR) AF confirmed before admission analyzed. Results: A total 273 enrolled between 2012 2015, whom 102 had (37.3%,...

10.36740/merkur202501104 article EN Polski Merkuriusz Lekarski 2025-01-01

Abstract Practices regarding indications and timing for transoesophageal echocardiography (TOE) before cardioversion (CV) of atrial fibrillation (AF) or left (LA) interventional procedures, preferred imaging techniques pharmacotherapy, in cases thrombus resistant to chronic oral anticoagulation (OAC) treatment, are largely unknown. The European Heart Rhythm Association (EHRA) conducted a survey capture contemporary clinical practice those areas AF care. A 22-item online questionnaire was...

10.1093/europace/euz257 article EN EP Europace 2019-08-20

The use of a blanking period (BP) after an atrial fibrillation (AF) ablation procedure is common practice, but recent data questions the benign nature early recurrences tachyarrhythmias (ERATs). A physician-based survey was carried out by European Heart Rhythm Association (EHRA) to investigate current definition and applicability BP ERAT management. An online questionnaire sent clinical interventional electrophysiologists. total 436 respondents (88% electrophysiologists) reported observing...

10.1093/europace/euac131 article EN EP Europace 2022-08-09

Abstract Electrical storm (ES) is a predictor of mortality, and its treatment challenging. Moreover, not all potential therapeutic strategies are available in hospitals, standardized approach among European centres lacking. The aim this Heart Rhythm Association (EHRA) survey was to assess the current management patients with ES both acute post-acute phases 102 different centres. A 20-item online questionnaire sent out EHRA Research Network Centres. median number treated annually per centre...

10.1093/europace/euac151 article EN cc-by EP Europace 2022-10-05

Catheter ablation (CA) of atrial fibrillation (AF) is the therapy choice for maintenance sinus rhythm in patients with symptomatic AF. Time towards interventional treatment and peri-procedural management undergoing AF may vary daily practice. The scope this European Heart Rhythm Association (EHRA) survey was to report current clinical practice regarding physician's adherence Society Cardiology Guidelines EHRA/HRS/ECAS expert consensus statement on CA This physician-based conducted among EHRA...

10.1093/europace/euac236 article EN cc-by-nc EP Europace 2022-12-13

Implantable cardioverter-defibrillator (ICD) may impact patients' life significantly. The aim of this survey was to analyse the ICD on quality (QoL) metrics from patient's perspective. 'Living with an ICD' a prospective, multicentre study online questionnaire submitted European Heart Rhythm Association (EHRA) Research Network centres as well patient associations 10 countries; it filled-in directly and personally by patients that were invited participate, minimal interaction or influence...

10.1093/europace/euac011 article EN EP Europace 2022-01-25

Electrophysiological (EP) operations that have traditionally involved long hospital lengths of stay (LOS) are now being undertaken as day case procedures. The coronavirus disease-19 pandemic served an impetus for many centres to shorten LOS EP This survey explores elective procedures in the modern era.An online consisting 27 multiple-choice questions was completed by 245 respondents from 35 countries. With respect de novo cardiac implantable electronic device (CIED) implantations, were...

10.1093/europace/euad297 article EN cc-by-nc EP Europace 2023-10-01

The aim of this study was to describe gender-related differences in clinical presentation, radiofrequency ablation (RFA) outcomes, and healthcare resource utilization a group patients with atrioventricular nodal reciprocating tachycardia (AVNRT) (AVRT). This single-centre, prospective, cohort which enroled 82 undergoing RFA AVNRT or AVRT. At baseline, all received assessment completed questionnaires concerning: socioeconomic status, disease-specific symptoms (Patient Perception Arrhythmia...

10.1093/europace/euu130 article EN EP Europace 2014-06-11

Abstract Aims Patients with atrial fibrillation who despite taking oral anti-coagulant therapy (OAT) suffer a stroke or systemic embolism (SSE) without vascular cause develop left appendage (LAA) thrombus (LAAT) should be considered as having malignant LAA. The optimal treatment strategy to reduce SSE risk in such patients is unknown. aim of the study investigate diagnostic and therapeutic pathways for LAA practiced European cardiac centres. Methods results An 18-item online questionnaire on...

10.1093/europace/euad204 article EN cc-by-nc EP Europace 2023-07-01

Guidelines have been introduced to provide "systematically developed statements assist practitioner and patient decisions about appropriate health care for specific clinical circumstances" [1]. Since their introduction, they a valuable tool large population of stakeholders, including physicians, patients, hospitals, educational bodies, manufacturers, providers insurers in medicine. While guidelines are meant help professionals taking routine decisions, there very few studies possessing the...

10.1111/jce.16561 article EN cc-by Journal of Cardiovascular Electrophysiology 2025-03-04

Despite treatment with anticoagulants, patients atrial fibrillation (AF) remain exposed to a relevant residual risk of stroke. It remains be proven if catheter ablation AF can lead an additional stroke protection benefit in these patients. Investigating possible protective by AF. Systematic review contemporary randomized controlled trials comparing vs. medical treatment. We searched MEDLINE, EMBASE and CENTRAL February 2025, pooled data through ratios (RRs) 95% confidence intervals (CIs),...

10.1016/j.hrthm.2025.05.021 article EN cc-by Heart Rhythm 2025-05-01

The aim of the study was to assess clinical efficacy antazoline, a first-generation anti-histaminic agent, in rapid conversion paroxysmal non-valvular atrial fibrillation (AF) sinus rhythm patients without heart failure.This single center, randomized, double blind, placebo-controlled, superiority trial. We enrolled with an AF episode lasting less than 43 h, stable cardiopulmonary condition. Subjects who fulfilled selection criteria were randomly assigned receive intravenously either placebo...

10.1093/europace/euw384 article EN EP Europace 2016-11-02

Cardiovascular diseases account for 43% of deaths in Poland. The COVID-19 pandemic increased the number cardiovascular by as much 16.7%. Lipid metabolism disorders are observed about 20 million Poles. usually asymptomatic, they cause a significant increase risk diseases. Up to 20% patients who experience an acute coronary syndrome (ACS) may recurrence event within year, and up 40% these be re-hospitalized. Within 5 years after myocardial infarction, 18% suffer second ACS 13% have got stroke....

10.33963/kp.a2023.0162 article EN Kardiologia Polska 2023-08-26

While detailed and heavily referenced guidelines consensus manuscripts are useful documents for the purpose of defining a point in historical evolution clinical practice,1-3 they can often be too dense to real value front-line clinicians may not always read from beginning end. The this document is provide concise description methodology upcoming AF ablation document. This will comprehensive guide catheter written by wide range recognized experts field under umbrella European Cardiac...

10.1111/jce.16254 article EN cc-by-nc Journal of Cardiovascular Electrophysiology 2024-05-12

Abstract Aims Catheter ablation is the most effective rhythm-control option in patients with atrial fibrillation (AF) and currently considered an mainly for improving symptoms. We aimed to assess impact of catheter on hard clinical outcomes. Methods results performed a systematic review randomized controlled trials (RCTs) comparing vs. optimized medical treatment. searched MEDLINE, EMBASE, CENTRAL 8 January 2024, published ≤10 years. pooled data through risk ratio (RR) mean differences...

10.1093/ehjopen/oeae058 article EN cc-by European Heart Journal Open 2024-07-01

ARTICLE Antazoline in atrial fibrillation 1 increased health care costs caused by a growing number of consults the emergency department (ED) due to acute debilitating symptoms. 2Although debate about supremacy heart INTROduCTION The clinical significance (AF) extends further than just risk excessive stroke -related disability and mortality is related emotional stress

10.20452/pamw.16234 article EN Polskie Archiwum Medycyny Wewnętrznej 2022-03-16

Patients with structurally normal hearts (SNH) suffering from ventricular tachycardia (VT) or frequent premature contractions (PVCs) are at low risk of sudden cardiac death. Any treatment ameliorates symptoms without a substantial influence on survival.The aim this study was to prospectively evaluate the health-related quality life (QoL) patients SNH undergoing elective radiofrequency ablation (RFA) VT PVCs.Patients scheduled for RFA PVCs in were enrolled. They underwent 24-h Holter ECG and...

10.1080/ac.67.2.2154205 article EN Acta Cardiologica 2012-04-01

INTRODUCTION Numerous studies described the effectiveness and safety of antazoline in pharmacological cardioversion short‑duration atrial fibrillation (AF). However, there are no data on comparison antiarrhythmic drugs listed clinical guidelines. OBJECTIVES The aim study was to assess comparative antazoline‑based propafenone‑based strategies AF performed our emergency department. PATIENTS AND METHODS We conducted a retrospective case‑control based analysis medical records patients undergoing...

10.20452/pamw.3452 article EN Polskie Archiwum Medycyny Wewnętrznej 2016-06-24
Coming Soon ...